PRESS RELEASE published on 08/04/2026 at 07:00, 1 month 13 days ago Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease. Expanded indication for broad protection. Key milestone in public health EU Sanofi Infants MenQuadfi Meningococcal Disease
BRIEF published on 07/30/2026 at 15:43, 1 month 18 days ago Sanofi Releases Half-Year Financial Report for 2026 AMF Financial Report SEC Sanofi 2026
PRESS RELEASE published on 07/30/2026 at 15:38, 1 month 18 days ago Press Release: Sanofi’s half-year financial report for 2026 Sanofi announces availability of its half-year financial report for 2026, now accessible on www.sanofi.com, filed with AMF and submitted to SEC Investors Financial Report Sanofi Half-year 2026
BRIEF published on 07/10/2026 at 18:35, 2 months 7 days ago Sanofi Reports Share and Voting Rights Information for June 2026 Voting Rights French Commercial Code Issued Shares Financial Regulations Sanofi
BRIEF published on 07/10/2026 at 18:35, 2 months 7 days ago Sanofi: Update on voting rights and shares in June 2026 Voting Rights Investors Actions Sanofi June 2026
PRESS RELEASE published on 07/10/2026 at 18:30, 2 months 7 days ago Sanofi: Information concerning the total number of voting rights and shares - June 2026 Sanofi discloses total voting rights and shares as per French Commercial Code and AMF regulations for June 30, 2026 Voting Rights French Commercial Code Shares AMF Regulations Sanofi
BRIEF published on 07/01/2026 at 07:35, 2 months 16 days ago Sanofi Releases Aide-Mémoire for Q2 2026 Financial Results Investors Transparency Sanofi Financial Modeling Q2 2026 Results
PRESS RELEASE published on 07/01/2026 at 07:30, 2 months 16 days ago Press Release: Availability of the aide-mémoire for Q2 2026 results Sanofi announced availability of the Q2 2026 results aide-mémoire for financial modelling, covering non-comparable items and share count, to be published on July 30, 2026 Investors Sanofi Aide-mémoire Financial Modelling Q2 2026 Results
BRIEF published on 06/23/2026 at 07:20, 2 months 24 days ago Wayrilz's Approval for the TPI in Japan Sanofi Japan Approval BTK Inhibitor Wayrilz Thrombocytopenia
PRESS RELEASE published on 06/23/2026 at 07:15, 2 months 24 days ago Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Sanofi's Wayrilz (rilzabrutinib) approved in Japan for treating immune thrombocytopenia. Approval based on LUNA 3 study demonstrating platelet response and symptom improvements Japan Sanofi ITP Wayrilz Immune Thrombocytopenia
Published on 09/17/2026 at 22:15, 1 hour 57 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 1 hour 57 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 2 hours 7 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 8 hours 17 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 8 hours 47 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 19:00, 5 hours 11 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 5 hours 13 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 5 hours 46 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 6 hours 1 minute ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 6 hours 25 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 6 hours 32 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 6 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 17 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
